Multisystem Inflammatory Syndrome in Adult Patients Associated with COVID-19 in Clinical Practice of a Neurologist: A Case Report
Multisystem inflammatory syndrome is the most complex and severe manifestation of the new coronavirus infection COVID-19 in both children and adolescents and adults. A clinical case of multisystem inflammatory syndrome associated with a new coronavirus infection (COVID-19) in an adult patient is presented, as a rare, crucial variant of the course of disease caused by SARS-CoV-2 coronavirus, with damage of nervous, respiratory, cardiovascular, hepatobiliary and other systems. This article discusses the relevance of clinical manifestations of multisystem inflammatory syndrome associated with COVID-19 infection in the presented case according to literature data and criteria of the US Centers for Disease Control and Prevention (CDC), as well as clinical and laboratory features of the described clinical case. Clinicians are required to consider the diagnosis of multisystem inflammatory syndrome in individuals with hyperinflammatory disease and severe extrapulmonary multiple organ dysfunction occurring within 2-12 weeks after the prior COVID-19 or contact with a person diagnosed with COVID-19.